Changing epidemiology of bacterial meningitis

被引：41

作者：

Dery M.A. ^{[1
]}

Hasbun R. ^{[1
]}

机构：

[1] Infectious Diseases Section, Department of Medicine, Tulane University School of Medicine, New Orleans, LA 70112

来源：

Current Infectious Disease Reports | 2007年 / 9卷 / 4期

关键词：

Meningitis; Bacterial Meningitis; Conjugate Vaccine; Invasive Pneumococcal Disease; Meningococcal Disease;

D O I：

10.1007/s11908-007-0047-7

中图分类号：

学科分类号：

摘要：

Immunization against the most common meningeal pathogens is the leading factor associated with decreased incidence of bacterial meningitis in countries where routine vaccination is available. This is most dramatically illustrated by the reduction in the incidence of Haemophilus influenzae type b meningitis. The incidence of bacterial meningitis has decreased by 55% since the introduction of the H. influenzae type b conjugate vaccine in 1990. H. influenzae occurred primarily in children younger than 5 years of age, and so the median age of patients with bacterial meningitis has now increased to 39 years of age in the United States, and the leading pathogen is currently Streptococcus pneumoniae. Three other control measures (ie, universal screening and antibiotic prophylaxis of pregnant women for Group B streptococci and the implementation and availability of the S. pneumoniae and Neisseria meningitidis conjugate vaccines) have likely further decreased the incidence of these meningeal pathogens. Lastly, the worldwide emergence of multidrug-resistant pneumococci has complicated the empiric therapy of bacterial meningitis. Copyright © 2007 by Current Medicine Group LLC.

引用

页码：301 / 307

页数：6

共 48 条

[11]

Prevention of Haemophilus influenzae type b disease, MMWR Morb Mortal Wkly Rep, 35, (1986)

[12]

Clark S.C., Control of pneumococcal disease in the United Kingdom - the start of a new era, J Med Microbiol, 55, pp. 975-980, (2006)

[13]

Peltola H., Kilpi T., Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines, Lancet, 340, pp. 592-594, (1992)

[14]

Kyaw M., Christie P., Jones I., Campbell H., The changing epidemiology of bacterial meningitis and invasive non-meningitic bacterial disease in Scotland during the period of 1983-99, Scand J Infect Dis, 34, pp. 289-298, (2002)

[15]

Wenger J.D., DiFabio J., Landaverde J.M., Et al., Introduction of Hib conjugate vaccines in the non-industrialized world: Experience in four 'newly adopting' countries, Vaccine, 18, pp. 736-742, (1999)

[16]

Dickinson F.O., Perez A., Bacterial meningitis in children and adolescents: An observational study based on the national surveillance system, BMC Infect Dis, 5, (2005)

[17]

Cowgill K.D., Ndiritu M., Nyiro J., Et al., Effectiveness of Haemophilus influenzae type b conjugate vaccine introduction into routine childhood immunization in Kenya, JAMA, 296, pp. 671-678, (2006)

[18]

Broadhurst L.E., Erickson R.L., Kelley P.W., Decreases in invasive Haemophilus influenzae diseases in US Army children, 1984 through 1991, JAMA, 269, pp. 227-231, (1993)

[19]

Peltola H., Aavitsland P., Hansen K.G., Et al., Perspective: A five-country analysis of the impact of four different Haemophilus influenzae type b conjugates and vaccination strategies in Scandinavia, J Infect Dis, 179, pp. 223-229, (1999)

[20]

Daza P., Banda R., Misoya K., Et al., The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in Malawi, a country with high human immunodeficiency virus prevalence, Vaccine, 24, pp. 6232-6239, (2006)

← 1 2 3 4 5 →